The purpose of this research study is to develop the Alzheimer's Disease and Related Dementias Palliative Care (ADRD-PC) program for persons with late-stage ADRD and their family members during a hospitalization. For patients, we aim to learn if this program of dementia-specific palliative is effective to reduce hospital transfers, improve symptom treatment, supplement supportive services and reduce nursing home transitions. For family members, we aim to improve communication with clinicians, shared decision-making and decrease distress.
To assess three different metrics of healthcare access as surrogate measures of immunization coverage.
The purpose of this study is to develop a natural language processing (NLP)-based software tool to identify information related to rigor and transparency from RCT reports. These tools will assist stakeholders of clinical research in maintaining high reporting standards, synthesizing information on methodological quality, and fostering open science practices.
The goal of this project is to prototype and conduct usability testing on the "reserve a study room" function of UNC library website.
This pilot project will test a new wearable device which will monitor elbow motion in people who are recovering from stroke.
The purpose of this study is to learn more about the experiences of families with children who have peanut or other food allergies. It also explores parents' (or other caregivers') and adolescents' perceptions of available food allergy treatments, as well as clinical research options.
The purpose of this study is to understand how employees behavior is impacted by their resilience.
Our study seeks to understand how effective a lecture series on common palliative care topics is and how effective changes made over time to the curriculum have been.
The purpose of this research study is to examine the impact of prior experiences on investment behavior and performance.
The purpose of this study is to define patient populations who may recover left atrial mechanical function rapidly (<24 hours) following cardioversion. Defining these characteristics will help us weigh the risks and benefits of anticoagulation following cardioversion.